Alira Health

Outlook 2023: Firms Prepare For ‘World Where Health Care Has No Limits’

What’s ahead for device companies in 2023? In the latest publication by Medtech Insights by Pharma Intelligence, executives at top device companies and other stakeholders share their expectations. Deepak Sahu, Partner at Alira Health, has shared his predictions for the year ahead alongside executives from Edwards, Medtronic, Qiagen, and more.

Reports and White Papers
Published on:
February 2, 2023

Our integrated and multidisciplinary team of over 600 scientists, strategists, economists, clinicians, and biostatisticians collaborate across our North American, European, and Asian offices and advise 80% of the top 50 MedTech companies and 75% of the top 50 Pharma companies.

Related news

News September 1, 2026
Alira Health Advises Mindful Capital Partners on the Sale of Portfolio Company Sidam S.r.l. to Plastiflex Group
Alira Health is pleased to have acted as Vendor Due Diligence Advisor to Mindful Capital Partners, an independent cross-border private equity firm focused on mid-market companies across(...)
MedTech
Reports and White Papers September 1, 2026
Global Medtech Contract Development and Manufacturing Market H1 2026 M&A Update
Learn about the H1 2026 M&A trends in the medtech CDMO market including deal activity, geographic distribution of transactions, and target end-markets.
CDMO MedTech
Articles August 19, 2026
How to Develop Global Clinical Evidence Strategies for Regulatory Success in Medtech
Discover how a strategically planned clinical evidence generation strategy can support global device approval, maximize evidence value, and prepare for international expansion.
MedTech Regulatory
Events July 24, 2026
MedTech World Asia 2026
Meet our team at MedTech World Asia 2026 and learn how our integrated model can support your international expansion and drive commercial success.
MedTech
Articles July 24, 2026
How Pharma and Medtech Convergence Is Changing DDS Partner Selection in 2026
Learn how pharma and medtech convergence is reshaping drug delivery system partner selection, from combination products and regulatory readiness to integrated execution.
Drug Delivery MedTech Pharma
Articles May 12, 2026
Frequently Asked Questions on the Strategic Value of Dual Branding in Pharma
Discover how dual branding in pharma enables pricing flexibility and expands access, and how to design a strategy that protects value and withstands scrutiny.
Interview Market Access Pharma
Articles April 24, 2026
From Approval to Adoption: A New Framework for Medtech Success
Medtech success requires more than approval. Discover how aligning evidence, patient needs, and market access drives adoption.
Interview MedTech Regulatory
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.